EV EGFR levels significantly correlated with tumour EGFR levels, tumour size and Ki67 tumour expression, suggesting that this microfluidic electrochemical immunosensor for EV EGFR may be useful in early diagnosis of breast cancer patients [31]. This evidence concerns the gene EGFR and breast carcinoma.